Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZIRCON: OBV/PTV/RTV +/- DSV +/- RBV in Pediatric HCV
NCT02486406Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Oct 2015
- Primary completion
- Nov 2020
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 3 trial of ombitasvir, paritaprevir, ritonavir, dasabuvir in hepatitis C (HCV), sponsored by AbbVie Inc.. Started Oct 2015; status: completed.
02
Drugs
ombitasvirparitaprevirritonavirdasabuvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02486406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02486406.